Adjuvant for intradermal vaccine developed to deal with a pandemic
A team of researchers from the U.S., Israel and Canada has developed an adjuvant for use as an intradermal vaccine to reduce deaths when pandemics occur. In their paper published in the journal Science Advances, the group ...